Creation lamis — ARRIVEDERCI POUR HOMME
Eau de toilette spray, intended for men, 100 ml.
- Risk level
- Serious risk
- Type
- Chemical
- Kategori
- Cosmetics
- Fare
- According to the list of ingredients the product contains 2-(4-tert-butylbenzyl) propionaldehyde (BMHCA), which is forbidden in cosmetic products. BMHCA may harm the reproductive system, may harm the health of the unborn child and may cause skin sensitisation.
- Origin
- United Arab Emirates
⚖️ Handlinger bestilt af myndigheder
- ▸ (to: Distributor) Ban on the marketing of the product and any accompanying measures
5414666007696
What is this? This is a men’s perfume called Creation lamis — ARRIVEDERCI POUR HOMME. It is a cosmetic product.
What's happening? The perfume contains a chemical that is not allowed in cosmetics. This chemical may harm the reproductive system, harm an unborn child, or cause skin reactions.
Does this affect me? If you have this perfume, you may be at risk. Pregnant women and people with sensitive skin are especially at risk.
What should I do? Stop using the perfume right away. Ask your pharmacist or doctor if you have any health concerns.
🤖 Denne letforståelige oversigt er automatisk genereret ud fra den officielle meddelelse fra myndigheden ved hjælp af AI. Den er udelukkende til generel information — ikke medicinsk rådgivning. Vedrørende beslutninger om din sundhed, skal du altid konsultere en farmaceut eller læge og læse den officielle kilde, der er linket nedenfor.
🔬 Medicinske/tekniske detaljer Til fagfolk
Risk level: Serious risk · Type: Chemical · Category: Cosmetics · Hazard: According to the list of ingredients the product contains 2-(4-tert-butylbenzyl) propionaldehyde (BMHCA), which is forbidden in cosmetic products. BMHCA may harm the reproductive system, may harm the health of the unborn child and may cause skin sensitisation. · Origin: United Arab Emirates
Alle oplysninger på denne side stammer fra den officielle meddelelse fra myndighederne. Vi oversætter og opsummerer den; vi tilføjer eller redigerer ikke fakta.
